Literature DB >> 11108836

Activation of p38 mitogen-activated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor.

M Matsumoto1, T Sudo, M Maruyama, H Osada, M Tsujimoto.   

Abstract

Tumor necrosis factor (TNF) induces osteoclast differentiation from bone marrow cells in the presence of macrophage colony-stimulating factor. Treatment of bone marrow cells with SB203580 but not PD98059 inhibited TNF-induced osteoclast differentiation. In RAW264 cells which differentiate into osteoclast-like multinucleated cells by TNF treatment alone, activation of p38 mitogen-activated protein (MAP) kinase induced by murine TNF was comparable to and independent of the receptor activator of necrosis factor-kappaB ligand. Moreover, the number of multinucleated osteoclasts induced by TNF in bone marrow cell cultures derived from p38 MAP kinase gene deficient mice was significantly less than that from control mice. These results indicate that the p38 MAP kinase pathway plays a crucial role in TNF-mediated osteoclast differentiation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11108836     DOI: 10.1016/s0014-5793(00)02231-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

Review 1.  Tumor necrosis factor-α signaling in macrophages.

Authors:  Narayanan Parameswaran; Sonika Patial
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2010       Impact factor: 1.807

2.  The paired-box homeodomain transcription factor Pax6 binds to the upstream region of the TRAP gene promoter and suppresses receptor activator of NF-κB ligand (RANKL)-induced osteoclast differentiation.

Authors:  Masakazu Kogawa; Koji Hisatake; Gerald J Atkins; David M Findlay; Yuichiro Enoki; Tsuyoshi Sato; Peter C Gray; Yukiko Kanesaki-Yatsuka; Paul H Anderson; Seiki Wada; Naoki Kato; Aya Fukuda; Shigehiro Katayama; Masafumi Tsujimoto; Tetsuya Yoda; Tatsuo Suda; Yasushi Okazaki; Masahito Matsumoto
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

Review 3.  The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis.

Authors:  G Schett; J Zwerina; G Firestein
Journal:  Ann Rheum Dis       Date:  2007-09-07       Impact factor: 19.103

4.  IL-1 mediates TNF-induced osteoclastogenesis.

Authors:  Shi Wei; Hideki Kitaura; Ping Zhou; F Patrick Ross; Steven L Teitelbaum
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

Review 5.  Focus on the p38 MAPK signaling pathway in bone development and maintenance.

Authors:  Cyril Thouverey; Joseph Caverzasio
Journal:  Bonekey Rep       Date:  2015-06-10

Review 6.  Advances in osteoclast biology: old findings and new insights from mouse models.

Authors:  James R Edwards; Gregory R Mundy
Journal:  Nat Rev Rheumatol       Date:  2011-03-08       Impact factor: 20.543

7.  P38 mitogen-activated protein kinase inhibitor, FR167653, inhibits parathyroid hormone related protein-induced osteoclastogenesis and bone resorption.

Authors:  Huiren Tao; Mina Okamoto; Masataka Nishikawa; Hideki Yoshikawa; Akira Myoui
Journal:  PLoS One       Date:  2011-08-23       Impact factor: 3.240

8.  Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain.

Authors:  Devki Sukhtankar; Alec Okun; Anupama Chandramouli; Mark A Nelson; Todd W Vanderah; Anne E Cress; Frank Porreca; Tamara King
Journal:  Mol Pain       Date:  2011-10-20       Impact factor: 3.395

Review 9.  Cells of the synovium in rheumatoid arthritis. Osteoclasts.

Authors:  Georg Schett
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

Review 10.  The molecular mechanism of osteoclastogenesis in rheumatoid arthritis.

Authors:  Nobuyuki Udagawa; Shigeru Kotake; Naoyuki Kamatani; Naoyuki Takahashi; Tatsuo Suda
Journal:  Arthritis Res       Date:  2002-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.